Fundraising Fox
Celldom
Founded 2016 · 8 employees on LinkedIn · 3 known investors
Find your way into Celldom
Sign up to see every warm intro you have to Celldom
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Celldom team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CellDom develops CloneXplorer, a live single-cell assay platform combining functional imaging, molecular readouts, and integrated cell retrieval for high-resolution cell analysis. The platform enables CAR T-cell potency testing, antibody/TCR discovery, cell line development, and precision medicine applications for research and therapeutic development teams.
Investors · 3
First In Ventureslisted by First In VenturesMiddletown · $50K – $200K
How we know: the VCSheet dataset · Not right? Tell us
Red Forest Capitallisted by Red Forest Capital
How we know: Red Forest Capital's portfolio page · Not right? Tell us
TSVClisted by TSVCSilicon Valley · $1M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Celldom do?
- CellDom develops CloneXplorer, a live single-cell assay platform combining functional imaging, molecular readouts, and integrated cell retrieval for high-resolution cell analysis. The platform enables CAR T-cell potency testing, antibody/TCR discovery, cell line development, and precision medicine applications for research and therapeutic development teams.
- Who are Celldom's investors?
- Celldom's investors include First In Ventures, Red Forest Capital, TSVC.